(Q41441667)

30 September 2017

title

Malignant lymphoma of follicular center cell origin in humans. IV. Small transformed (noncleaved) cell lymphoma of the non-Burkitt's type (English)

1 reference

30 September 2017

Malignant lymphoma of follicular center cell origin in humans. IV. Small transformed (noncleaved) cell lymphoma of the non-burkitt's type (English)

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

25 August 2023

0 references

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

25 August 2023

author name string

D. L. Oviatt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6192896

25 August 2023

J. B. Cousar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6192896

25 August 2023

J. M. Flexner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6192896

25 August 2023

P. J. Kurtin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6192896

25 August 2023

R. D. Collins

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6192896

25 August 2023

R. S. Stein

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6192896

25 August 2023

language of work or name

English

0 references

publication date

1 October 1983

1 reference

full work available at URL

30 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

25 August 2023

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

25 August 2023

1 reference

30 September 2017

volume

52

1 reference

30 September 2017

issue

7

1 reference

30 September 2017

page(s)

1196-1201

1 reference

The American Burkitt Lymphoma Registry: A Progress Report

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819831001%2952%3A7%3C1196%3A%3AAID-CNCR2820520712%3E3.0.CO%3B2-6

Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819831001%2952%3A7%3C1196%3A%3AAID-CNCR2820520712%3E3.0.CO%3B2-6

1.3-Bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP): A new therapeutic regimen for diffuse histiocytic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819831001%2952%3A7%3C1196%3A%3AAID-CNCR2820520712%3E3.0.CO%3B2-6

Immunologic characterization of human malignant lymphomas

21 January 2018

1

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

25 August 2023

Cancer Treatment Reports

2

61

971

Lukes

1977

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

Clinical Utility of Lymphocyte Surface Markers Combined with the Lukes-Collins Histologic Classification in Adult Lymphoma

25 August 2023

3

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

25 August 2023

Cancer Treatment Reports

4

66

1107

Sweet

1982

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

Malignant lymphomas of follicular center cell origin in man.III. Prognostic Features

25 August 2023

5

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

American Burkitt's lymphoma: a clinicopathologic study of 30 cases. I. Clinical factors relating to prolonged survival

25 August 2023

7

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

American Burkitt's lymphoma: a clinicopathologic study of 30 cases. II. Pathologic correlations

25 August 2023

8

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

Bone marrow involvement in Burkitt's lymphoma

25 August 2023

9

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

Combined modality treatment of American Burkitt's lymphoma

25 August 2023

10

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

Prognostic factors in Burkitt's lymphoma importance of total tumor burden

25 August 2023

11

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience

25 August 2023

12

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

Prolonged complete remission following high dose chemotherapy of burkitt's lymphoma in relapse

25 August 2023

13

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

Long-term remission in diffuse histiocytic lymphoma treated with combination sequential chemotherapy

25 August 2023

19

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

Non-Hodgkin's lymphoma in children. A comparative study of two modalities of therapy

25 August 2023

22

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

Nonparametric Estimation from Incomplete Observations

25 August 2023

23

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

25 August 2023

24

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

Studies of Burkitt lymphoma cells. I. Establishment of a cell line (B35M) and its characteristics.

25 August 2023

25

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

Immunoglobulin synthesis and secretion. VI. Synthesis and intracellular transport of immunoglobulin in nonsecretory lymphoma cells

25 August 2023

27

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

Non-endemic Burkitts's lymphoma. A B-cell tumor related to germinal centers

25 August 2023

29

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

A comparative study of Burkitt's and non-Burkitt's "undifferentiated" malignant lymphoma: immunologic, cytochemical, ultrastructural, cytologic, histopathologic, clinical and cell culture features

25 August 2023

30

1 reference

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19831001)52:7%3C1196::AID-CNCR2820520712%3E3.0.CO;2-6

25 August 2023

Identifiers

10.1002/1097-0142(19831001)52:7<1196::AID-CNCR2820520712>3.0.CO;2-6

1 reference

30 September 2017

1 reference